US$ 24.80
bpc 157 and cancer BPC-157 – Research Peptide BPC-157 - LeadWest Medical
Description
Several factors influence your optimal dose

Instant outputs: concentration (mcg/mL), volume per injection, doses per vial

Preferentially immunoglobulin (IgG) subclasses production in primary Sjgrens syndrome patients

Combined with other B Vitamins or Vitamin C, can play a comprehensive effect

The reason is bioavailability and dosing consistency
It also acts as a localised 5-alpha reductase inhibitor, reducing DHT at the scalp level
